Leaflet LACOSAMIDA FRESENIUS KABI 10mg / ml solution for infusion

Product code:
W69054001
Quantity:
1
Indicated for:
epilepsy
Route of administration:
infusion
Substance:
lacosamide (antiepileptic)
ATC
N03AX18 — Nervous system | Antiepileptics | Antiepileptics | Other antiepileptics

Precautions:

Driving impairment

This medicine may affect your ability to drive or use machines.

Dose adjustment in hepatic impairment

Dose adjustment may be needed in liver disease.

Dose adjustment in renal impairment

Dose adjustment may be needed in kidney disease.

Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Use during pregnancy only on medical advice.

Suicidal ideation / mental changes

Seek medical help if suicidal thoughts or major behavior changes occur.

Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

Lacosamide is an antiepileptic medication used for the treatment of partial-onset seizures, with or without secondary generalization. It works by stabilizing abnormal electrical activity in the brain.

The medication is administered orally or intravenously, as directed by a doctor. The dose is gradually adjusted to reduce the risk of side effects.

Side effects may include dizziness, nausea, fatigue, or balance disturbances. In rare cases, severe allergic reactions or cardiac arrhythmias may occur.

Lacosamide is not recommended for patients with hypersensitivity to this medication or certain cardiac conditions, such as second- or third-degree atrioventricular block.

General data about LACOSAMIDA FRESENIUS KABI 10mg / ml

Substance:
lacosamide
Date of latest medicines list:
01-09-2022
Product code:
W69054001
Concentration:
10mg / ml
Pharmaceutical form:
solution for infusion
Quantity:
1
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
FRESENIUS KABI DEUTSCHLAND GMBH - GERMANIA
Holder:
FRESENIUS KABI ROMANIA SRL - ROMANIA
Number:
14564/2022/01
Shelf life:
2 years-after packaging for sale; after the first opening of the bottle - it is used immediately

Pharmaceutical forms available for lacosamide

Concentrations available for lacosamide

  • 100mg
  • 10mg/ml
  • 150mg
  • 15mg/ml
  • 200mg
  • 50mg